Bioplatforms Australia congratulates Professor Peter Hoffmann from the University of South Australia on receiving the 2025 Australian Council of Graduate Research (ACGR) Award for Excellence in Industry Engagement. Professor Hoffmann, a long-standing collaborator of...
The Solutions for Manufacturing Advanced Regenerative Therapies (SMART CRC) has secured $65 million in federal government funding, launching a $238 million national initiative to revolutionise the manufacturing and delivery of life-changing therapies. Bioplatforms...
Bioplatforms Australia and Phenomics Australia are proud to announce a new national initiative aimed at advancing knowledge of causality and treatment of mental disorders through large-scale omics data generation and high throughput phenomics. This initiative responds...
Bioplatforms Australia is collaborating with Therapeutic Innovation Australia (TIA), Phenomics Australia, and the Australian Nuclear Science and Technology Organisation (ANSTO) to address the medical products challenge outlined in the 2021 National Research...
The 2024 Nobel Prize in Chemistry was awarded to the team behind the transformative AI tool AlphaFold. In a major achievement for life sciences and biomedical research, the tool developed by DeepMind and released in 2020 enables rapid, accurate prediction of protein...
Bioplatforms Australia, enabled by NCRIS investment in research infrastructure, is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability...
